ResearcherNational Health Research InstitutesNo recent work listed
Ming‐Chuan Hsu
Matched on ORCID iD 0000-0002-6327-4426; OpenAlex author ID A5008685459. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 2 papers
Papers 4
- Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer. Co-author DOI 10.1186/s13045-019-0769-7↗
- Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication. First author DOI 10.3390/jcm8060903↗
- Protein Arginine Methyltransferase 3 Enhances Chemoresistance in Pancreatic Cancer by Methylating hnRNPA1 to Increase ABCG2 Expression. Co-author DOI 10.3390/cancers11010008↗
- The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer. First author DOI 10.18632/oncotarget.11256↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Li‐Tzong Chen · 4 shared papers, 2016–2019 · strength 0.38
- Paper Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication. DOI 10.3390/jcm8060903↗
- Paper Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer. DOI 10.1186/s13045-019-0769-7↗
- Paper Protein Arginine Methyltransferase 3 Enhances Chemoresistance in Pancreatic Cancer by Methylating hnRNPA1 to Increase A… DOI 10.3390/cancers11010008↗
- Mei‐Ren Pan · 4 shared papers, 2016–2019 · strength 0.38
- Paper Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication. DOI 10.3390/jcm8060903↗
- Paper Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer. DOI 10.1186/s13045-019-0769-7↗
- Paper Protein Arginine Methyltransferase 3 Enhances Chemoresistance in Pancreatic Cancer by Methylating hnRNPA1 to Increase A… DOI 10.3390/cancers11010008↗
- Wen‐Chun Hung · 4 shared papers, 2016–2019 · strength 0.38
- Paper Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication. DOI 10.3390/jcm8060903↗
- Paper Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer. DOI 10.1186/s13045-019-0769-7↗
- Paper Protein Arginine Methyltransferase 3 Enhances Chemoresistance in Pancreatic Cancer by Methylating hnRNPA1 to Increase A… DOI 10.3390/cancers11010008↗
- Yan‐Shen Shan · 3 shared papers, 2016–2019 · strength 0.25
- Paper Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer. DOI 10.1186/s13045-019-0769-7↗
- Paper Protein Arginine Methyltransferase 3 Enhances Chemoresistance in Pancreatic Cancer by Methylating hnRNPA1 to Increase A… DOI 10.3390/cancers11010008↗
- Paper The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer. DOI 10.18632/oncotarget.11256↗
- Yu‐Hsuan Hung · 1 shared paper, 2019 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.